GCTK News

Glucotrack, Inc. (NASDAQ: GCTK) (Glucotrack or the Company) today announced definitive agreements for convertible notes with an aggregate principal amount of approximately $11.5 million, including approximately $4.5 million of new cash investment and approximately $4.5 million of existing notes...

Lkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced the expansion of its ai platform into three dedicated business divisions: ai Pipeline, ai Talent, and ai Accelerator. The new structure reflects the growth of the Company's actual intelligence-driven platform...

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced a collaboration with San Diego State University's (SDSU) Fowler College of Business, expanding the ai Futures Lab and strengthening Lkahis growing network of partner academic institutions. The partnership with SDSU...

Glucotrack, Inc. (Nasdaq: GCTK) (Glucotrack or the Company), a healthcare technology and biopharmaceutical company operating Lkahi Therapeutics, today announced that it will effect a 1-for-15 reverse stock split (the Reverse Stock Split) of its issued and outstanding common stock par value $0.001...

Lkahi Therapeutics Inc., a subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced that it has started its initial Good Manufacturing Practice (GMP) manufacturing campaign for LT-100 (pure honeybee venom), the Company's lead development candidate for osteoarthritis pain.The advancement of...

Lkahi Therapeutics, a subsidiary of Glucotrack, Inc. (Nasdaq: GCTK), today announced the continued participation of the University of Georgias Student Industry Fellows Program in the ai Futures Lab. The renewed collaboration expands Lkahis growing nationwide network of academic institutions...

Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-market session. The company's market cap stands at $1.7 million. GlucoTrack (NASDAQ:GCTK) shares moved upwards byread more...

Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq's stockholders' equity...

Glucotrack, Inc. (NASDAQ: GCTK) ("Glucotrack" or the "Company") today announced definitive agreements for approximately $5.5 million in financing from participating institutional investors, including a $2.0 million equity financing priced at $0.75 per unit and a $3.5 million follow-on investment in...